리서치 & 클리핑

041960 코미팜

4 min read

041960 코미팜

기본 정보

  • 섹터: KOSDAQ:제조
  • 시가총액: 5,740억원 (2026-06-30 기준)
  • 첫 등장: 2026-06-09 (누적 1일)
  • 태그: 매크로/바이오헬스 · 동물의약품 · 백신 · 신약
  • 네이버 금융: 🔗

기업개요

  • 동사는 1972년 설립되어 경기도 시흥시와 충남 예산군에서 동물용 백신과 치료제를 생산하며, 호주 현지법인을 계열사로 보유하고 있음.
  • 동물용의약품 부문에서는 돼지 유행성 설사백신의 중국 판매허가를 취득하여 수출을 시작하였고, 아프리카돼지열병백신 개발을 위해 야외임상실험을 진행 중임.
  • 인체의약품 부문에서는 항암제 신약 코미녹스(PAX-1)의 다국가 임상시험을 추진하며, 마약성 진통제 대체 혁신 신약 개발에 역량을 집중하고 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자전일 종가종가등락률시간외vol색깔smart외연금투투개그외
2026-08-077,6308,320🔴 +9.04%—×3.5🟢 외인+4.0억+3.5+0.0+0.1+0.5-4.3+0.2
2026-08-067,6407,630🔵 -0.13%—×1.0🟢 외인+3.6억+3.6+0.0+0.0+0.0-3.0-0.6
2026-08-057,4007,640🔴 +3.24%—×1.2🟢 외인+2.4억+2.4+0.0+0.0+0.0-1.1-1.2
2026-08-047,2207,400🔴 +2.49%—×1.2🟢 외인+2.4억+2.4+0.0+0.0+0.0-2.4+0.0
2026-08-037,2907,220🔵 -0.96%—×1.0🔻 개인-0.0억-0.0+0.0-0.0+0.0+0.2-0.1
2026-07-316,8007,290🔴 +7.21%—×1.1🟢 외인+4.4억+4.4+0.0+0.0+0.0-4.0-0.5
2026-07-306,6806,800🔴 +1.80%—×1.0🟢 외인+1.9억+1.9+0.0-0.0+0.0-1.9+0.0
2026-07-296,7806,680🔵 -1.47%—×1.8🔻 개인-0.9억-0.9+0.0-0.2+0.0+1.1+0.0
2026-07-286,9906,780🔵 -3.00%—×1.2⚫ 그외-0.2억-0.2+0.0+0.2+0.0-0.6+0.6
2026-07-277,0006,990🔵 -0.14%—×0.7🔻 개인-0.6억-0.6+0.0-0.1+0.0+0.5+0.2
2026-07-247,0507,000🔵 -0.71%—×0.8🟢 외인+0.3억+0.3+0.0+0.1+0.0-0.5+0.0
2026-07-237,0807,050🔵 -0.42%—×0.7🔻 개인-0.7억-0.7+0.0+0.0+0.0+0.6+0.1
2026-07-227,0807,080⚪ +0.00%—×0.5🔻 개인-0.7억-0.7+0.0-0.1+0.0+0.8+0.0
2026-07-217,0007,080🔴 +1.14%—×1.1🔻 개인+0.7억+0.7+0.0+0.1+0.0+2.2-2.9
2026-07-207,2807,000🔵 -3.85%—×0.7🔻 개인-1.2억-1.2+0.0+0.0+0.0+1.2+0.0
2026-07-167,6807,280🔵 -5.21%—×0.8🔻 개인-1.4억-1.4+0.0-0.1+0.0+2.0-0.5
2026-07-156,9707,680🔴 +10.19%—×1.4🟢 외인+4.5억+4.5+0.0+0.1+0.0-1.6-3.0
2026-07-147,2706,970🔵 -4.13%—×1.0🟢 외인+0.5억+0.5+0.0-0.0+0.0-0.6+0.1
2026-07-137,5007,270🔵 -3.07%—×1.0🔻 개인-1.4억-1.4+0.0+0.0+0.0+2.4-0.9
2026-07-107,4107,500🔴 +1.21%—×0.5🟢 외인+2.2억+2.2+0.0+0.0+0.0-0.2-2.0
2026-07-097,3607,410🔴 +0.68%—×0.6🔻 개인-1.8억-1.8+0.0-0.1+0.0+3.0-1.2
2026-07-087,6507,360🔵 -3.79%—×0.8🔻 개인-0.3억-0.3+0.0+0.1+0.0+0.2+0.1
2026-07-077,8007,650🔵 -1.92%—×0.6🔻 개인-1.0억-1.0+0.0-0.0+0.0+1.0+0.0
2026-07-067,9007,800🔵 -1.27%—×0.6🔻 개인-1.5억-1.5+0.0+0.0+0.0+1.3+0.1
2026-07-037,8707,900🔴 +0.38%—×0.4🔻 개인-0.5억-0.5+0.0-0.0+0.0+0.3+0.2
2026-07-027,9607,870🔵 -1.13%—×1.0🔻 개인-2.1억-2.6+0.0-0.0+0.5+1.4+0.7
2026-07-017,7707,960🔴 +2.45%—×0.5⚫ 그외-0.7억-1.6+0.0+0.0+0.8-0.3+1.0
2026-06-307,7307,770🔴 +0.52%—×0.5🔻 개인-1.4억-1.4+0.0-0.3+0.0+1.7+0.0
2026-06-297,5007,730🔴 +3.07%—×0.9🟢 외인+1.6억+1.6+0.0+0.2+0.0-1.8-0.0
2026-06-267,9907,500🔵 -6.13%—×0.9🔻 개인-3.0억-3.0+0.0+0.0+0.0+3.0+0.0
2026-06-258,1207,990🔵 -1.60%—×0.4🔻 개인-3.6억-3.6+0.0-0.0+0.0+3.3+0.4
2026-06-247,7308,120🔴 +5.05%—×0.6🔻 개인-0.6억-0.6+0.0+0.0+0.6+0.0
2026-06-237,8807,730🔵 -1.90%—×0.7🔻 개인-5.4억-5.4+0.0-0.1+4.4+1.1
2026-06-228,0707,880🔵 -2.35%—×0.5🔻 개인-0.8억-0.8+0.0+0.1+0.6+0.1
2026-06-198,6508,070🔵 -6.71%—×0.8🔻 개인-8.1억-8.1+0.0-0.0+7.9+0.1
2026-06-188,8408,650🔵 -2.15%—×1.0🔻 개인-6.5억-6.5+0.0+0.1+6.8-0.4
2026-06-178,4208,840🔴 +4.99%—×1.1🟢 외인+6.1억+6.1+0.0+0.0-3.8-2.3
2026-06-168,2608,420🔴 +1.94%—×0.6🔻 개인-3.8억-3.8+0.0+0.3+4.1-0.6
2026-06-158,5608,260🔵 -3.50%—×0.6🔻 개인-6.3억-6.3+0.0-0.0+6.6-0.3
2026-06-128,3708,560🔴 +2.27%—×0.9🟢 외인+8.1억+8.1+0.0+0.0-5.3-2.8
2026-06-118,0008,370🔴 +4.62%—×0.7🔻 개인-4.3억-4.3+0.0-0.0+4.4-0.0
2026-06-108,3308,000🔵 -3.96%—×1.2🔻 개인-6.2억-6.2+0.0-0.2+8.3-1.9
2026-06-097,1208,330🔴 +16.99%—×3.5🟢 외인+8.0억+8.0+0.0+0.2-6.1-2.0
2026-06-087,0807,120🔴 +0.56%—×0.9🔻 개인-2.8억-2.8+0.0+0.0+3.2-0.4
2026-06-056,8207,080🔴 +3.81%—×0.9🔻 개인-6.3억-6.3+0.0-0.2+6.5+0.0
2026-06-047,1306,820🔵 -4.35%—×0.9🟡 금투-0.3억-0.3+0.0+0.2+0.1+0.0
2026-06-027,3007,130🔵 -2.33%—×0.9🟢 외인+3.3억+3.3+0.0-0.0-2.9-0.3
2026-06-017,4807,300🔵 -2.41%—×1.4🟢 외인+2.2억+2.2+0.0+0.0-2.3+0.0
2026-05-297,6907,480🔵 -2.73%—×0.8🔻 개인-5.9억-5.9+0.0-0.1+6.3-0.4

일자별 사유 (최신 위)

2026-07-15

  • 사유: —
  • 섹터 컨텍스트: KOSDAQ:제조 (smart +1,144억)
  • 매크로 원인: HLB 리보세라닙 FDA 제조 리스크 해소 기대에 그룹주 무더기 상한가, 미프진 허가 검토·항암신약 모멘텀 가세 (보통)

2026-06-09

  • 사유: —
  • 섹터 컨텍스트: KOSDAQ:제조 (smart +1,603억)
  • 매크로 원인: 코스피·코스닥 급반등 동조 + 美당뇨학회 비만약·ADC 기술수출 K바이오 모멘텀, 개별 호재 가세 (보통)

백링크